傲农生物：2025年前三季度净利润约4.14亿元

Group 1 - The core point of the article is that Aonong Biological (SH 603363) reported a decline in revenue and net profit for the first three quarters of 2025, indicating a challenging financial environment for the company [1] Group 2 - Aonong Biological's revenue for the first three quarters of 2025 was approximately 6.335 billion yuan, representing a year-on-year decrease of 8.52% [1] - The net profit attributable to shareholders of the listed company was around 414 million yuan, with a basic earnings per share of 0.16 yuan [1] - As of the report date, Aonong Biological's market capitalization stood at 13.4 billion yuan [1]